1. Home
  2. DPC vs BLCO Comparison

DPC vs BLCO Comparison

Compare DPC & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DPC Holdings PLC Ordinary Shares

DPC

DPC Holdings PLC Ordinary Shares

N/A

Current Price

$41.63

Market Cap

6.4B

Sector

N/A

ML Signal

N/A

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.72

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DPC
BLCO
Founded
N/A
1853
Country
Canada
Employees
N/A
N/A
Industry
Ophthalmic Goods
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.1B
IPO Year
2026
2022

Fundamental Metrics

Financial Performance
Metric
DPC
BLCO
Price
$41.63
$16.72
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$18.45
AVG Volume (30 Days)
1.1M
372.3K
Earning Date
N/A
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$5,101,000,000.00
Revenue This Year
N/A
$8.65
Revenue Next Year
N/A
$5.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.47
52 Week Low
$37.65
$13.77
52 Week High
$57.25
$18.92

Technical Indicators

Market Signals
Indicator
DPC
BLCO
Relative Strength Index (RSI) 45.12 39.71
Support Level $38.13 $16.21
Resistance Level $46.64 $17.20
Average True Range (ATR) 2.87 0.46
MACD 0.11 -0.15
Stochastic Oscillator 39.62 5.36

Price Performance

Historical Comparison
DPC
BLCO

About DPC DPC Holdings PLC Ordinary Shares

DPC Holdings PLC is a manufacturer of complex precision cast components for aerospace engines and industrial gas turbines. It produces metal components and specialized products for aerospace and industrial applications and operates manufacturing facilities across multiple locations globally.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: